Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone vs Dexamethasone on 28-day Mortality in COVID-19 Patients on Oxygen
2020-005883-78Phase 3Completed
- Sponsor
- Centre Hospitalier René-Dubos
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of prednisolone in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Centre Hospitalier René-Dubos. Primary endpoint: Vital status at day 28. Started Dec 2020; status: completed.
02
Drugs
prednisolone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-005883-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005883-78.